Canadian Online Pharmacy

CDER New March 14, 2013

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

March 13, 2013


New and Generic Drug Approvals

March 12, 2013

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Androgel testosterone Gel, Metered; Transdermal Abbvie Labeling Revision
Androgel testosterone Gel; Transdermal Abbvie Labeling Revision
Azasite azithromycin Solution/Drops; Ophthalmic Inspire Manufacturing Change or Addition
Duraclon clonidine hydrochloride Injectable; Injection Mylan Institutional Manufacturing Change or Addition
Pioglitazone Hydrochloride pioglitazone hydrochloride Tablet; Oral Dr Reddys Labs Ltd Approval
Quinapril Hydrochloride; Hydrochlorothiazide quinapril hydrochloride; hydrochlorothiazide Tablet; Oral Apotex Corp Approval
Trelstar triptorelin pamoate Injectable; Intramuscular Watson Labs Labeling Revision
Trelstar triptorelin pamoate Injectable; Intramuscular Watson Labs Labeling Revision
Trelstar triptorelin pamoate Injectable; Intramuscular Watson Labs Labeling Revision
Viread tenofovir disoproxil fumarate Tablet; Oral Gilead Sciences Inc Manufacturing Change or Addition
Xalkori crizotinib Capsule; Oral Pfizer Manufacturing Change or Addition
Zoledronic Acid zoledronic acid Injectable; Injection Emcure Pharma Approval

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery